Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
Common Stock, $0.001 par value per share · CUSIP: 98943L107
Event date: 2025-01-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Walters William T
Shares: 6,500,000.00 · Class: 9.1%
- WALTERS GROUP
Shares: 6,500,000.00 · Class: 9.1%
- Walters, Susan B.
Shares: 6,500,000.00 · Class: 9.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001689655-25-000004
- Form type
- SCHEDULE 13G/A
- Filer
- Walters William T
- CIK
- CIK 1689655
- Filed
- Jan 22, 2025
- Reporting period
- Jan 21, 2025
- Description
- Schedule 13G beneficial ownership